Next Article in Journal
Effects of Inflorescence Stem Structure and Cell Wall Components on the Mechanical Strength of Inflorescence Stem in Herbaceous Peony
Previous Article in Journal
2-Decenoic Acid Ethyl Ester, a Compound That Elicits Neurotrophin-like Intracellular Signals, Facilitating Functional Recovery from Cerebral Infarction in Mice
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Synthesis, Spectral and Antibacterial Studies of Copper(II) Tetraaza Macrocyclic Complexes

1
Department of Chemistry, Kakatiya University, Warangal 506 009, A.P, India
2
Department of Chemistry, National Dong Hwa University, Hualien 974, Taiwan
3
Department of Laboratory Medicine and Biotechnology, Tzu Chi University, Hualien 97004, Taiwan
*
Authors to whom correspondence should be addressed.
Int. J. Mol. Sci. 2012, 13(4), 4982-4992; https://doi.org/10.3390/ijms13044982
Submission received: 8 March 2012 / Revised: 11 April 2012 / Accepted: 12 April 2012 / Published: 19 April 2012
(This article belongs to the Section Materials Science)

Abstract

:
A novel family of tetraaza macrocyclic Cu(II) complexes [CuLX2] (where L = N4 donor macrocyclic ligands) and (X = Cl, NO3 ) have been synthesized and characterized by elemental analysis, magnetic moments, IR, EPR, mass, electronic spectra and thermal studies. The magnetic moments and electronic spectral studies suggest square planar geometry for [Cu(DBACDT)]Cl2 and [Cu(DBACDT)](NO3)2 complexes and distorted octahedral geometry to the rest of the ten complexes. The biological activity of all these complexes against gram-positive and gram-negative bacteria was compared with the activity of existing commercial antibacterial compounds like Linezolid and Cefaclor. Six complexes out of twelve were found to be most potent against both gram-positive as well as gram-negative bacteria due to the presence of thio group in the coordinated ligands.

1. Introduction

Macrocyclic ligands are considerably attractive in the quest for new chemistry, because they offer a wide variety of donor atoms, ionic charges, coordination numbers and geometry of the resultant complexes [15]. The understanding of the metal ion chemistry of macrocyclic ligands has important implications for a range of chemical and biochemical applications [6,7]. Many metal complexes of naturally occurring porphyrins, corrins and phthalocyanines have been investigated because of their potential as dyestuffs or pigments [811]. Macrocyclic ligand complexes are of great importance in enhancing various industrial applications and in a number of biological processes such as photosynthesis and dioxygen transport [12] catalytic properties, potential applications as metal extractants, radiotherapeutic and medical imaging agents and to potency towards DNA binders [13] with a high potential in anti-tumor therapy, has provided a motivation for investigation of the metal ion chemistry of these systems, as well as of cyclic ligand systems [8,9,14,15]. Cu(II) is the most studied metal ion among all the transition metal ions [16,17]. Cu(II) complexes are known to play a significant role either in naturally occurring biological systems or as pharmacological agents [18,19]. In connection with previous investigations [1,2,20], on the coordinating properties of tetraaza macrocycles, and in order to isolate new transition metal complexes with potential antimicrobial properties, we have studied the synthesis, spectroscopic and biochemical aspects of tetraaza macrocyclic complexes of copper(II) derived from o-phthalaldehyde with various diamines.

2. Results and Discussion

A series of twelve tetraaza macrocyclic Cu(II) complexes were synthesized by treating CuCl2·2H2O and Cu(NO3)2·3H2O with the six macrocyclic Schiff base ligands. All the complexes are stable to the atmosphere. The complexes are soluble in chloroform, DMSO, DMF and aqueous methanol. The elemental analyses (Table 1) are consistent with the proposed structure of the complexes. The molar conductance values of the complexes 1.5 and 2.5 in DMF at room temperature (65.0 and 68.3 ohm−1·cm2·mol−1) confirm their 1:2 electrolytic natures and the low molar conductance values of other complexes indicate non-electrolytic nature.

2.1. Infrared Spectral Data

The main bands and their assignments are listed in Table 2. In the IR spectra of macrocyclic Cu(II) complexes, a medium intensity band due to υ(C=N) was shifted towards lower side about 20–33 cm−1 compared to the ligand spectra and was appeared in the range of 1598–1573 cm−1 [21]. The appearance of a lower intensity band in the region of 524–505 cm−1 corresponds to the υ(M–N) vibration supports the fact that the ligands coordinate to the metal ions through the nitrogen of C=N group in all the complexes [2224]. A band present in the range of 318–302 cm−1 in the spectra of 1.1, 1.2, 1.3, 1.4 and 1.6 complexes indicating the presence of two chlorides in trans position around copper center [17,25]. The presence of chloride ions in 1.1, 1.2, 1.3, 1.4 and 1.6 complexes are detected by the addition of silver nitrate reagent leading to the formation of white precipitate. However, in the case of complex 1.5, this band is not observed indicating chloride ions are not in the coordination sphere. The coordination of the nitrate groups have been confirmed in the complexes 2.1, 2.2, 2.3, 2.4 and 2.6 by the band in the region of 230–240 cm−1 may be assigned [9] to υ(M–O) of the ONO2 group [26]. The additional bands observed around ~1410, 1300 and 1020 cm−1 [25] were obtained in the spectra of the nitrato complexes, which consistent [26] with the monodentate nature of the nitrato group [25,27,28]. The absence of these bands was observed in case of complex 2.5 indicating nitrate groups are not in the coordination sphere. The macrocyclic Cu(II) compounds (1.2 and 1.6) contain a broad band in the region 3505– 3374 cm−1 due to the presence of lattice water molecules[18,22].

2.2. EPR Spectral Data

The EPR spectra of the Cu(II) complexes have been recorded at room temperature as well as at liquid nitrogen temperature and their gll and g values have been calculated. The observed data show that gll = 2.085–2.219 and g = 2.018–2.046 (Table 3). The values of gll and g are closer to 2 and gll > g. This suggests that the unpaired electron is in the dx2-y2 orbital and hence, 2B1 is the ground state. It should be noted that for an ionic environment gll > 2.3, while for a covalent environment gll < 2.3. The copper complexes show gll < 2.3 indicating their considerable covalent character [9,29]. The g values are related by the expression G = (gll − 2)/(g − 2) which suggests an exchange interaction between copper centers in the polycrystalline solid. According to Hathway [30] if G > 4, the exchange interaction is negligible. In the present case, the axial symmetry parameter, G, lies in the range 4.025–5.896, which indicates no considerable exchange interaction in these solid complexes.

2.3. Electronic Spectra and Magnetic Data

The magnetic moment of all the Cu(II) complexes at room temperature lie in the range of 1.86–1.98 B.M. given in Table 1, corresponding to one unpaired electron. This indicates that these complexes are monomeric in nature and the absence of metal-metal interaction [17]. The electronic spectra of the complexes [Cu(L)X2](X = Cl, NO3 ) display two characteristic bands in the region 21226–22801 cm−1 and 16008–18348 cm−1 these may be assigned to 2B1g2Eg and 2B1g2A1g transitions respectively. The third band assigned to 2B1g2B2g transition band is usually not observed as a separate band in the tetragonal field. Therefore, it may be concluded that all the [Cu(L)X2] complexes show distorted octahedral structure (Scheme) [31]. The complexes [Cu(L)]X2 display broad band in the region 18181–18457 cm−1 and 13065–13524 cm−1 corresponding to transitions 2B1g2Eg and 2B1g2A1g which suggests the square planar geometry [19].

2.4. Thermal Analysis

Thermograms of TGA and DTA of macrocyclic Cu(II) compounds were recorded in nitrogen atmosphere at a heating rate of 10 °C/min. In the thermogram of complexes [Cu(TBACD)Cl2]·2H2O (1.2) and [Cu(TBAHD)Cl2]·2H2O (1.5), the initial weight loss of 15.36% (Calcd 15.28%) and 14.45% (Calcd 14.37%) at 70–110 °C corresponding to loss of two lattice held water molecules [18,22]. This fact was further supported by their DTA curves, which contain endothermic peaks in the temperature range 90–125 °C. The TGA decomposition curve, a peak corresponding to the loss of organic moiety in the temperature range of 238–252 °C was observed. On the other hand, the thermograms of other macrocyclic Cu(II) compounds showed only a single decomposition curve in the region 220–260 °C corresponding to the loss of organic moiety. Above 455 °C, organic moieties in macrocyclic Cu(II) compounds were decomposed leading to the formation of copper oxide.

2.5. Mass Spectral Analysis

In the mass spectra of respective macrocyclic Cu(II) complexes, molecular ion peaks, were observed at different m/z (M+/[M + Na]+) values. The molecular ion peaks and isotopic pattern of Cu(II) complexes shows different m/z values with different intensities. The mass spectra contain molecular ion peaks at m/z 511 (M+, complex 1.1), 517 (M+, complex 1.2), 507 (M+, complex 1.3), 543 (M+, complex 1.4), 483 (M+, complex 1.5), 517 (M+, complex 1.6), 563 (M+, complex 2.1), 586 ([M + Na]+, complex 2.1), 533 (M+, complex 2.2), 560 (M+, complex 2.3), 583 ([M + Na]+, complex 2.3), 595 (M+, complex 2.4), 535 (M+, complex 2.5), and 565 (M+, complex 2.6). This data is in good agreement with the respective molecular formulae.
Based on the physicochemical and the spectral studies the tentative structures proposed for the complexes are shown in Scheme 1.

2.6. Biological Results and Discussion

Twelve chemically synthesized Cu(II) macrocyclic complexes were tested in vitro for their antibacterial activity against five test bacteria namely S. aeruginosa, S. epidermidis, B. pumilus, B. megaterium and P. aeruginosa. The minimum inhibitory concentrations of complexes were determined by liquid dilution method. The minimum inhibitory concentration at which no growth was observed was taken as the MIC values. All the complexes of the tested series possessed good antibacterial activity against both gram-positive bacteria and gram-negative bacteria. The higher antibacterial activity of the copper complexes is may be due to the change in structure due to coordination and chelating tends to make metal complexes act as more powerful and potent bactereostatic agents, thus inhibiting the growth of the bacteria. Six complexes out of twelve (1.4, 1.5, 1.6, 2.4, 2.5 & 2.6) were most potent against both gram-positive as well as gram-negative bacteria. However, complexes 1.1, 1.2, 1.3, 2.1, 2.2 & 2.3 were also showed noticeable MIC ranging from 1–16 μg/mL against S. aeruginosa, B. pumilus and B. megaterium (Table 5). The gram positive were much more susceptible to the series as compared to gram-negative bacteria. The twelve Cu (II) complexes were also compared with two commercial antibiotics namely Linezoid and Cefaclor. The six complexes 1.4, 1.5, 1.6, 2.4, 2.5 & 2.6 registered better antibacterial in comparison with commercial antibiotics. The activity of these complexes is due to the presence of thio group in the coordinated ligands. Comparison of MIC values (in μg/mL) of Cu(II) macrocyclic complexes and standard drugs against different bacteria are given in Figure 1.

3. Experimental Section

3.1. Materials and Methods

The metal salts CuCl2·2H2O and Cu(NO3)2·3H2O were purchased from E. Merck. All the chemicals used were of AR grade and were procured from Aldrich. All solvents used were of AR grade. Six macrocyclic ligands viz. 7,8,9,18,19,20-hexahydrodibenzo[g,p] [1,2,4,5,10,11,13,14]- octaazacyclooctadecine-8,19-dione [HBOADO], 7,8,17,18-tetrahydrodibenzo[f,n] [1,2,4,9,11,12]- hexaazacyclohexadecine-8,17-dione [TBACD], 7,8,9,10,19,20,21,22-octahydrodibenzo[c,m] [1,6,11,16]-tetraazacycloicosine [OBACI], 7,8,9,18,19,20-hexahydrodibenzo[g,p] [1,2,4,5,10,11,13,14]-octaazacyclooctadecine-8,19-dithione [HBOADT], 7,16-dihydrodibenzo[e,l] [1,3,8,10]-tetraazacyclo tetradecine-7,16-dithione [DBACDT] and 7,8,17,18-tetrahydrodibenzo[f,n] [1,2,4,9,11,12]-hexaazacyclohexadecine-8,17-dithione [TBAHD] were synthesized according to the procedure reported by shanker et al. [32]. Gram positive microorganisms like Staphylococcus aeruginosa (ATCC-29213), Staphylococcus epidermidis (MTCC-2639), Bacillus pumilus (MTCC-1456), Bacillus megaterium (MTCC-428) and gram negative microorganism like Pseudomonas aeruginosa (ATCC-27853) from IMTECH, Chandigarh were used for antibacterial studies.

3.2. Measurements

The elemental analyses were obtained by using a Perkin-Elmer-2400 CHN elemental analyzer. The complexes were analyzed for Cu(II) content gravimetrically by literature procedures (Vogel AI (1989) Vogel’s text book of quantitative chemical analysis, 5th edition Longman, Amsterdam) after decomposing the organic matter with a mixture of HNO3 and HCl and evaporating the residue to dryness with concentrated H2SO4. UV-Vis spectra were recorded on Shimadzu UV-160A spectrophotometer, EPR spectra were recorded on Varian E-112X-Q band EPR Spectrometer. IR spectra in KBr pellets on Perkin-Elmer-283 spectrophotometer. LC-ESI MS was used to obtain mass spectra. Gouy balance calibrated with Hg[Co(NCS)4] was used for the determination of magnetic susceptibilities of complexes in solid state at room temperature. Thermograms were recorded on mettler-TA-2000C model. TG-DSC equilibrated at 25 ± 0.05 °C. The electrical conductivities of 10−3 M solutions in dichloromethane were performed using Digisun Digital conductivity meter model DL-909.

3.3. Synthesis of Dichloro/Nitrato Cu(II) Complexes [CuLX2]

To a stirred solution of the respective copper salts (0.519 g, 0.003 mol) dissolved in methanol (~20 mL) in a round-bottomed flask, methanolic solution (~25 mL) of ligand (0.003 mol., viz. 1.17 g of HBOADO, 1.038 g of TBACD, 1.116 g of OBACI, 1.26 g of HBOADT, 1.044 g of DBACDT, 1.134 g of TBAHD respectively) were added with the help of a dropping funnel. The reaction mixture was stirred magnetically. The resulting solution was concentrated to 5 mL under reduced pressure and a few mL of diethyl ether was added to initiate the crystallization. The resulting precipitate was separated by suction filtration, washed several times with diethyl ether, dried in vacuo and was recrystallized using dichloromethane and diethyl ether solvent mixture.

4. Conclusions

In the present communication, we have synthesized and characterized twelve copper (II) complexes containing tetraaza macrocyclic ligands. Based on the analytical and spectral data, we assume that the complexes (1.5 & 2.5) are square planar and the rest of the complexes show distorted octahedral geometry. All the complexes of the tested series were found to have good antibacterial activity. Complexes 1.4, 1.5, 1.6, 2.4, 2.5 & 2.6 were most potent against both gram-positive as well as gram-negative bacteria due to the presence of thio group in the coordinated ligands.

Acknowledgments

The authors thank the University Grant Commission (UGC, F. No. 34-363/2008(SR)), New Delhi, India for financially supporting this research. We also thank the National Science Council and Tzu Chi University of Taiwan for supporting this research financially.

References

  1. Reddy, P.M.; Prasad, A.V.S.S.; Rohini, R.; Ravinder, V. Catalytic reduction of pralidoxime in pharmaceuticals by macrocyclic Ni(II) compounds derived from orthophthalaldehyde. Spectrochim. Acta A 2008, 70, 704–712. [Google Scholar]
  2. Reddy, P.M.; Prasad, A.V.S.S.; Shanker, K.; Ravinder, V. Synthesis, spectral studies and antibacterial activity of novel macrocyclic Co(II) compounds. Spectrochim. Acta A 2007, 68, 1000–1006. [Google Scholar]
  3. Lim, I.-T.; Choi, K.-Y. One-dimensional hydrogen-bonded infinite chain from nickel(II) tetraaza macrocyclic complex and 1,2-cyclopentanedicarboxylate ligand. Int. J. Mol. Sci 2011, 12, 2232–2241. [Google Scholar]
  4. Reddy, P.M.; Ho, Y.-P.; Shanker, K.; Rohini, R.; Ravinder, V. Physicochemical and biological characterization of novel macrocycles derived from o-phthalaldehyde. Eur. J. Med. Chem 2009, 44, 2621–2625. [Google Scholar]
  5. Borisova, N.E.; Reshetova, M.D.; Ustynyuk, Y.A. Metal-free methods in the synthesis of macrocyclic Schiff bases. Chem. Rev 2006, 107, 46–79. [Google Scholar]
  6. Ma, W.; Tian, Y.-P.; Zhang, S.-Y.; Wu, J.-Y.; Fun, H.-K.; Chantrapromma, S. Synthesis and characterization of 1,8-bis(ferrocenylmethyl)-5,5,12,12,14-hexamethyl-1,4,8,11- tetraazacyclotetradecane, a macrocyclic ligand and its complexes. Transition Met. Chem 2006, 31, 97–102. [Google Scholar]
  7. Martin, E.M.; Bereman, R.D.; Singh, P. X-ray crystallographic studies of nickel(II) complexes of tetradentate [N2S2]2-ligands. 3. A stepwise distortion from square-planar to pseudotetrahedral geometries. Inorg. Chem 1991, 30, 957–962. [Google Scholar]
  8. Verma, S.; Chandra, S.; Dev, U.; Joshi, N. Synthesis, spectral and biological studies of nitrogen-sulphur donor macrocyclic ligands and their transition metals complexes. Spectrochim. Acta A 2009, 74, 370–374. [Google Scholar]
  9. Khan, T.A.; Tabassum, S.; Azim, Y.; Shakir, M. Synthesis and physico-chemical studies on 18-membered octaazamacrocyclic complexes of Mn(II), Co(II), Ni(II), Cu(II), and Zn(II) ions. Synth. React. Inorg. Met. Org. Chem 2004, 34, 1305–1318. [Google Scholar]
  10. Gupta, S.K.; Kushwah, Y.S. Mononuclear iron(III)macrocyclic complexes derived from 4-methyl-2,6-di(formyl/benzoyl)phenol and diamines: Synthesis, spectral speciation and electrochemical behaviour. Polyhedron 2001, 20, 2019–2025. [Google Scholar]
  11. Qian, M.; Gou, S.-H.; Ju, H.-X.; Huang, W.; Duan, C.-Y.; You, X.-Z. A mononuclear manganese(III) complex of an asymmetric macrocyclic ligand with a ring contraction [MnHL2(ClO4)](ClO4)·2.5H2O. Transit. Met. Chem 2000, 25, 584–588. [Google Scholar]
  12. Chandra, S.; Gupta, K. Chromium(III), manganese(II), iron(III), cobalt(II), nickel(II) and copper(II) complexes with a pentadentate, 15-membered new macrocyclic ligand. Transit. Met. Chem 2002, 27, 196–199. [Google Scholar]
  13. Liu, J.; Lu, T.-B.; Deng, H.; Ji, L.-N.; Qu, L.-H.; Zhou, H. Synthesis, DNA-binding and cleavage studies of macrocyclic copper(II) complexes. Transit. Met. Chem 2003, 28, 116–121. [Google Scholar]
  14. Jubert, C.; Mohamadou, A.; Guillon, E.; Barbier, J.-P. Molecular structure and spectroscopic characterization of cobalt and copper complexes with a hexadentate nitrogen ligand, 1,10-bis(2-pyridylmethyl)-1,4,7,10-tetraazadecane. Polyhedron 2000, 19, 1447–1453. [Google Scholar]
  15. Grguric, S.R.; Sabo, T.J. Synthesis and characterization of sym-cis- and unsym-cis-(ethylenediamine-N,N1-Di-3-Propionato)cobalt(III) complexes with symmetrical N,N1-substituted diamines. Synth. React. Inorg. Met. Org. Chem 1999, 29, 1567–1578. [Google Scholar]
  16. Ajibade, P.A.; Zulu, N.H. Metal complexes of diisopropylthiourea: Synthesis, characterization and antibacterial studies. Int. J. Mol. Sci 2011, 12, 7186–7198. [Google Scholar]
  17. Reddy, P.M.; Prasad, A.V.S.S.; Ravinder, V. Synthesis, spectral characterization, catalytic and antibacterial activity of macrocyclic CuII compounds. Transit. Met. Chem 2007, 32, 507–513. [Google Scholar]
  18. Budige, G.; Puchakayala, M.R.; Kongara, S.R.; Hu, A.; Vadde, R. Synthesis, characterization and biological evaluation of mononuclear Co(II), Ni(II), Cu(II) and Pd(II) complexes with new N2O2 Schiff base ligands. Chem. Pharm. Bull 2011, 59, 166–171. [Google Scholar]
  19. Chandra, S.; Jain, D.; Sharma, A.K.; Sharma, P. Coordination modes of a Schiff base pentadentate derivative of 4-aminoantipyrine with cobalt(II), nickel(II) and copper(II) metal ions: Synthesis, spectroscopic and antimicrobial studies. Molecules 2009, 14, 174–190. [Google Scholar]
  20. Reddy, P.M.; Prasad, A.V.S.S.; Reddy, C.K.; Ravinder, V. Synthesis of new macrocyclic rhodium(III) compounds and their utility as catalysts for the oxidation of ascorbic acid. Transit. Met. Chem 2008, 33, 251–258. [Google Scholar]
  21. Shanker, K.; Rohini, R.; Ravinder, V.; Reddy, P.M.; Ho, Y.-P. Ru(II) complexes of N4 and N2O2 macrocyclic Schiff base ligands: Their antibacterial and antifungal studies. Spectrochim. Acta A 2009, 73, 205–211. [Google Scholar]
  22. Geeta, B.; Shravankumar, K.; Reddy, P.M.; Ravikrishna, E.; Sarangapani, M.; Reddy, K.K.; Ravinder, V. Binuclear cobalt(II), nickel(II), copper(II) and palladium(II) complexes of a new Schiff-base as ligand: Synthesis, structural characterization, and antibacterial activity. Spectrochim. Acta A 2010, 77, 911–915. [Google Scholar]
  23. Shakir, M.; Varkey, S.P.; Kumar, D. Binuclear transition metal complexes of Schiff base macrocycles containing the furanyl moiety. Synth. React. Inorg. Met. Org. Chem 1994, 24, 941–952. [Google Scholar]
  24. Chandra, S.; Gupta, N.; Gupta, R. Novel copper(II) homobinuclear macrocyclic complexes: Cyclic voltammetry, biological properties and spectral studies. Spectrochim. Acta A 2006, 63, 587–593. [Google Scholar]
  25. Reddy, M.B.; Shanker, K.; Rani, P.U.; Rohini, R.; Reddy, C.K.; Ravinder, V. New cobalt(II) tetraaza macrocyclic complexes: Synthesis, spectral and antimicrobial studies. Int. J. ChemTech. Res 2007, 84, 971–977. [Google Scholar]
  26. Shakir, M.; Chishti, H.; Azim, Y.; Begum, N. Synthesis and characterization of hexaazamacrocyclic complexes with Co(II), Ni(II), Cu(II), and Zn(II) derived from phthalaldehyde and 2,6-diaminopyridine. Synth. React. Inorg. Met. Org. Chem 2004, 34, 809–818. [Google Scholar]
  27. Chandra, S.; Sangeetika, X. EPR, magnetic and spectral studies of copper(II) and nickel(II) complexes of Schiff base macrocyclic ligand derived from thiosemicarbazide and glyoxal. Spectrochim. Acta A 2004, 60, 147–153. [Google Scholar]
  28. Shakir, M.; Chishti, H.-T.-N.; Chingsubam, P. Metal ion-directed synthesis of 16-membered tetraazamacrocyclic complexes and their physico-chemical studies. Spectrochim. Acta A 2006, 64, 512–517. [Google Scholar]
  29. Bazzicalupi, C.; Bencini, A.; Berni, E.; Bianchi, A.; Borsari, L.; Giorgi, C.; Valtancoli, B.; Lodeiro, C.; Lima, J.C.; Parola, A.J.; et al. Protonation and coordination properties towards Zn(II), Cd(II) and Hg(II) of a phenanthroline-containing macrocycle with an ethylamino pendant arm. Dalton Trans 2004, 591–597. [Google Scholar]
  30. Hathaway, B.J.; Tomlinson, A.A.G. Copper(II) ammonia complexes. Coord. Chem. Rev 1970, 5, 1–43. [Google Scholar]
  31. Singh, D.; Kumar, R.; Tyagi, P. Template synthesis, spectroscopic studies and biological screening of macrocyclic complexes derived from thiocarbohydrazide and benzil. Transit. Met. Chem 2006, 31, 970–973. [Google Scholar]
  32. Shanker, K.; Reddy, P.M.; Rohini, R.; Ravinder, V. Synthesis and spectral studies of novel biologically active macrocycles derived from O-phthalaldehyde. Pharm. Lett 2009, 1, 97–107. [Google Scholar]
Figure 1. Comparison of MIC values (in μg/mL) of Cu(II) macrocyclic complexes and standard drugs against different bacteria.
Figure 1. Comparison of MIC values (in μg/mL) of Cu(II) macrocyclic complexes and standard drugs against different bacteria.
Ijms 13 04982f1
Scheme 1. Representative structures of copper complex.
Scheme 1. Representative structures of copper complex.
Ijms 13 04982f2
Table 1. Physical, analytical and electronic spectral data of macrocyclic Cu(II) complexes.
Table 1. Physical, analytical and electronic spectral data of macrocyclic Cu(II) complexes.
Comp. No.Cu(II) Compound/Molecular FormulaΛMμeff (B.M.)λmax (cm−1)Analyses (%) Found (Calculated)

CHNCu
1.1.[Cu(HBOADO)Cl2]
C18H16Cl2N8O2Cu
16.21.9616008, 2122642.38 (42.32)3.18 (3.16)22.04 (21.94)12.36 (12.44)
1.2.[Cu(TBACD)Cl2]·2H2O
C18H18Cl2N6O4Cu
14.01.9817348, 2280141.33 (41.83)3.52 (3.51)16.23 (16.26)12.25 (12.30)
1.3.[Cu(OBACI)Cl2]
C24H28Cl2N4Cu
13.51.9617857, 2198856.88 (56.86)5.57 (5.57)11.02 (11.05)12.56 (12.53)
1.4.[Cu(HBOADT)Cl2]
C18H16Cl2N8S2Cu
12.41.9417847, 2125540.01 (39.82)2.84 (2.97)20.72 (20.64)11.55 (11.70)
1.5.[Cu(DBACDT)]Cl2
C18H12Cl2N4S2Cu
65.01.9113065, 1818144.42 (44.77)2.68 (2.50)11.72 (11.60)13.07 (13.16)
1.6.[Cu(TBAHD)Cl2]·2H2O
C18H18Cl2N6S2Cu
16.51.9217699, 2252741.95 (41.82)3.50 (3.51)16.22 (16.26)12.24 (12.29)
2.1.[Cu(HBOADO)(NO3)2]
C18H16N10O8Cu
15.31.9316422, 2171238.23 (38.34)3.02 (2.86)24.81 (24.84)11.34 (11.27)
2.2.[Cu(TBACD)(NO3)2]
C18H14N8O8Cu
16.11.8917758, 2295440.42 (40.49)2.84 (2.64)21.10 (20.99)11.87 (11.90)
2.3.[Cu(OBACI)(NO3)2]
C24H28N6O6Cu
14.81.9418201, 2214751.48 (51.47)5.05 (5.04)15.06 (15.01)11.38 (11.35)
2.4.[Cu(HBOADT)(NO3)2]
C18H16N10S2O6Cu
12.91.8618348, 2187536.24 (36.27)2.68 (2.71)23.42 (23.50)10.72 (10.66)
2.5.[Cu(DBACDT)](NO3)2
C18H12N6S2O6Cu
68.31.8913524, 1845740.31 (40.34)2.16 (2.26)15.74 (15.68)11.91 (11.86)
2.6.[Cu(TBAHD)(NO3)2]
C18H14N8S2O6Cu
15.41.9317700, 2275638.12 (38.20)2.54 (2.49)19.82 (19.80)11.34 (11.23)
Table 2. Infrared spectral data of macrocyclic Cu(II) complexes.
Table 2. Infrared spectral data of macrocyclic Cu(II) complexes.
Comp. No.Cu(II) CompoundSelected IR Bands (cm−1)

υC=NυNHυCu–NAnion Peaks
1.1.[Cu(HBOADO)Cl2]15783320516307
1.2.[Cu(TBACD)Cl2]2·H2O15753326518304
1.3.[Cu(OBACI)Cl2]1596-520318
1.4.[Cu(HBOADT)Cl2]15903324524302
1.5.[Cu(DBACDT)]Cl21598-506-
1.6.[Cu(TBAHD)Cl2]2·H2O15853383520314
2.1.[Cu(HBOADO)(NO3)2]15803318510235
2.2.[Cu(TBACD)(NO3)2]15733325515230
2.3.[Cu(OBACI)(NO3)2]1595-518240
2.4.[Cu(HBOADT)(NO3)2]15873326520230
2.5.[Cu(DBACDT)](NO3)21595-505-
2.6.[Cu(TBAHD)(NO3)2]15803379518235
Table 3. EPR spectral data of macrocyclic Cu(II) compounds.
Table 3. EPR spectral data of macrocyclic Cu(II) compounds.
Comp. No.Cu(II) Compoundg11g⊥|g|avgG
1.1.[Cu(HBOADO)Cl2]2.1192.0242.0554.958
1.2.[Cu(TBACD)Cl2]·2H2O2.2122.0432.0994.930
1.3.[Cu(OBACI)Cl2]2.1182.0212.0535.619
1.4.[Cu(HBOADT)Cl2]2.2192.0392.0995.615
1.5.[Cu(DBACDT)]Cl22.2202.0462.1044.782
1.6.[Cu(TBAHD)Cl2]·2H2O2.1712.0292.0765.896
2.1.[Cu(HBOADO)(NO3)2]2.1082.0222.0504.909
2.2.[Cu(TBACD)(NO3)2]2.1772.0402.0854.425
2.3.[Cu(OBACI)(NO3)2]2.0852.0182.0404.722
2.4.[Cu(HBOADT)(NO3)2]2.1652.0302.0755.500
2.5.[Cu(DBACDT)](NO3)22.1612.0402.0804.025
2.6.[Cu(TBAHD)(NO3)2]2.1102.0192.0495.789
Table 5. Minimum inhibitory concentration (MIC) of Cu(II) macrocyclic complexes against test bacteria.
Table 5. Minimum inhibitory concentration (MIC) of Cu(II) macrocyclic complexes against test bacteria.
Comp. No.Macrocyclic Cu(II) ComplexesMIC (μg/mL)

SaBpBmPaSe
1.1.[Cu(HBOADO)Cl2]86101612
1.2.[Cu(TBACD)Cl2]·2H2O81016812
1.3.[Cu(OBACI)Cl2]16108129
1.4.[Cu(HBOADT)Cl2]244162
1.5.[Cu(DBACDT)]Cl2284<161
1.6.[Cu(TBAHD)Cl2]·2H2O442162
2.1.[Cu(HBOADO)(NO3)2]10<168>1610
2.2.[Cu(TBACD)(NO3)2]101081612
2.3.[Cu(OBACI)(NO3)2]16816>16>16
2.4.[Cu(HBOADT)(NO3)2]224161
2.5.[Cu(DBACDT)](NO3)2244<162
2.6.[Cu(TBAHD)(NO3)2]424162
Linezolid444<16<16
Cefaclor288<162
Sa: S. aeruginosa (ATCC-29213); Bp: B. pumilus (MTCC-1456); Bm: B. megaterium (MTCC-428); Pa: P. aeruginosa (ATCC-27853); Se: S. epidermidis (MTCC-2639).

Share and Cite

MDPI and ACS Style

Reddy, P.M.; Rohini, R.; Krishna, E.R.; Hu, A.; Ravinder, V. Synthesis, Spectral and Antibacterial Studies of Copper(II) Tetraaza Macrocyclic Complexes. Int. J. Mol. Sci. 2012, 13, 4982-4992. https://doi.org/10.3390/ijms13044982

AMA Style

Reddy PM, Rohini R, Krishna ER, Hu A, Ravinder V. Synthesis, Spectral and Antibacterial Studies of Copper(II) Tetraaza Macrocyclic Complexes. International Journal of Molecular Sciences. 2012; 13(4):4982-4992. https://doi.org/10.3390/ijms13044982

Chicago/Turabian Style

Reddy, Puchakayala Muralidhar, Rondla Rohini, Edulla Ravi Krishna, Anren Hu, and Vadde Ravinder. 2012. "Synthesis, Spectral and Antibacterial Studies of Copper(II) Tetraaza Macrocyclic Complexes" International Journal of Molecular Sciences 13, no. 4: 4982-4992. https://doi.org/10.3390/ijms13044982

Article Metrics

Back to TopTop